The incidence of osteoporosis in postmenopausal women was 34%.
绝经期妇女中骨质疏松发生率为34%。
In postmenopausal women, risk was associated with higher TZD dose.
绝经后女性骨折风险与服用大剂量tzd有关。
Letrozole may be used for postmenopausal women who have completed 5 yr of daily tamoxifen.
来曲唑可用于连续5年、每天服用三苯氧胺的绝经后妇女。
Raloxifene is also used in prevention and treatment of osteoporosis in postmenopausal women.
雷洛昔芬还被用于防治绝经后妇女骨质疏松症。
Objective To observe the effects of tibolone on climacteric syndrome in postmenopausal women.
目的探讨替勃龙治疗妇女绝经期综合征的疗效及副反应情况。
It is commonly thought of as a problem for postmenopausal women, but it can also occur in men.
它通常被认为是绝经后妇女才会发生的问题,但是它也可以发生于男性。
Men and postmenopausal women need only around 8 mg a day, while premenopausal women need 18 mg a day.
男性和绝经后妇女每天只需8毫克,而绝经前的妇女每天则需18毫克。
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
雷洛昔芬是用来预防和治疗绝经后妇女的骨质疏松症的。
Purpose To study the relationship between osteoporosis of postmenopausal women and leads of estrogen.
目的研究妇女绝经后骨质疏松与雌激素的关系。
Urinary tract infection. Recurrent urinary tract infections are a problem for many postmenopausal women.
尿路感染。复发性尿路感染是许多绝经后妇女的一个问题。
What Is the Influence of Weight Change on Forearm Bone Mineral Density in Peri - and Postmenopausal Women?
体重的改变对处于绝经期和绝经后妇女的前臂骨矿物质密度将产生什么影响?
Fact: While it's true the disease is more common in postmenopausal women, breast cancer can affect people of any age.
事实:虽然绝经后的妇女更容易患乳腺癌,但任何年龄段的妇女都有患癌的可能性。
Obese postmenopausal women are at increased risk, but there is no evidence that dietary modification decreases risk.
绝经后肥胖妇女危险性增加,但没有证据证明改变饮食会降低危险。
This is because postmenopausal women rarely retain the flaxen locks of their youth, of course eventually becoming grey grannies.
这也是为什么绝经后的女性很少能保留她们少女时代淡黄色的头发,而变成白头发的老奶奶。
Results showed that ApoE gene polymorphism have some effect on lipid metabolism in peripheral blood of postmenopausal women.
表明载脂蛋白e基因多态性对绝经期妇女血脂的代谢有一定的影响。
Postmenopausal women over 50 should also be getting these tests, as heart disease remains the biggest killer of women as well as men.
超过50岁的绝经妇女也应接受这些测试,因为无论对妇女还是男人,心脏病都是最大的杀手。
The researchers analyzed the hormone levels in 739 postmenopausal women in the cohort who were not on hormone replacement therapy.
研究人员分析了队列中739例绝经后妇女的激素水平,她们未接受激素替代治疗。
But Thompson said this was only relevant for people at particular risk of heart disease, such as men aged over 40 and postmenopausal women.
但是汤马森说,这研究结果仅仅适用于有特殊罹患心脏病风险的人群,比如说,超过40岁的男性和已绝经的女性。
The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women.
绝经妇女中激素替代疗法对低密度脂蛋白和对氧磷酯酶活性的影响。
Methods. We evaluated the presence of endplate sclerosis, osteophytes, and narrowing of disc Spaces in 434 Japanese postmenopausal women.
方法:我们评价了434名绝经后日本女性终板硬化,骨赘,椎间隙狭窄的发病情况。
CONCLUSION: Postmenopausal women taking TZDs and the subset of men taking both loop diuretics and TZDs were at increased risk for fractures.
结论:绝经后女性服用TZD与男性同时服用髓袢利尿剂和TZD骨折风险均增加。
The objective was to explore the relationship between polymorphism of the calcitonin receptor gene and BMD in postmenopausal women in Anhui.
为此,本研究特探讨降钙素受体基因多态性与安徽地区绝经后妇女BMD的关系。
This is the first large study testing the effectiveness of an antidepressant specifically in peri - and postmenopausal women with depression.
这是首次进行这种大型研究,考查抗抑郁药对于绝经前后女性抑郁症状的疗效。
To do this, they studied 65,893 postmenopausal women participating in the women's Health Initiative (WHI) who had no previous history of CVD.
为了做到这一点,他们研究了加入妇女健康倡议组织、没有CVD病史的65,893绝经后女性。
Osteoporosis: of old postmenopausal women is the most important problem in the world, and that, it is also the important task of gerontology.
老年妇女绝经后骨质疏松是当今世界多数国家面临重要问题,也是老年医学的重要研究课题。
Objective:To evaluate the effect and safety of oral administration of residronate sodium in treatment of postmenopausal women with osteoporosis.
目的:探讨利塞膦酸钠治疗绝经后骨质疏松症的临床疗效,并评价其安全性。
Results The prevalence of urinary incontinence of postmenopausal women was 61.0%. Stress urinary incontinence had the highest prevalence (64.5%).
结果绝经后妇女总的尿失禁患病率为61.0%,其中以张力性尿失禁所占比例最高(64.5%);
Results The prevalence of urinary incontinence of postmenopausal women was 61.0%. Stress urinary incontinence had the highest prevalence (64.5%).
结果绝经后妇女总的尿失禁患病率为61.0%,其中以张力性尿失禁所占比例最高(64.5%);
应用推荐